Articles tagged "Liver cirrhosis"

2019 American Transplant Congress
Liver Transplant Candidate Attitudes towards Organs from Increased Risk Donors: A Single Center Survey
S. S. Humar, J. Liu, N. Pinzon, D. Kumar, M. Bhat, L. Lilly, N. Selzner
University Health Network, Toronto, ON, Canada
*Purpose: Increased Risk Donors (IRDs) are a significant proportion of the deceased organ donor pool but may be declined by patients on the liver transplant…
2019 American Transplant Congress
Patients With Persistently Low MELD-Na Scores Continue To Be At Risk Of Liver Related Death
N. Mazumder, K. Atiemo, S. Montag, A. Daud, A. Kho, M. Abecassis, J. Levitsky, D. Ladner
Northwestern Memorial Hospital, Chicago, IL
*Purpose: The Model for End Stage Liver Disease-Sodium (MELD-Na) score is a reliable predictor of 90-day mortality however its long term predictive ability is unclear,…
2019 American Transplant Congress
The Impact of Sleeve Gastrectomy Following Liver Transplant in Patients with Non-Alcoholic Steatosis: A Five-Year Experience
M. C. Morris¹, A. D. Jung¹, Y. Kim¹, V. K. Dhar¹, S. Shah¹, D. Schauer², E. Smith², T. Diwan¹
¹Surgery, University of Cincinnati, Cincinnati, OH, ²Medicine, University of Cincinnati, Cincinnati, OH
*Purpose: Non-alcoholic steatohepatitis (NASH) cirrhosis is an increasingly common indication for liver transplantation (LT) in the United States and obese patients continue to be at…
2019 American Transplant Congress
Gender Disparities In Cirrhosis: New Findings In A Large Pretransplant Population
N. Mazumder, K. Atiemo, A. Daud, L. Zhao, M. Abecassis, J. Levitsky, D. P. Ladner
Northwestern Memorial Hospital, Chicago, IL
*Purpose: There is concern that female patients may suffer worse outcomes than their male counterparts while awaiting liver transplant. Studies on this topic often use…
2019 American Transplant Congress
Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization
G. Cullaro¹, E. C. Verna², J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY
*Purpose: In an effort to standardize SLKT utilization, UNOS/OPTN implemented a new SLKT policy on August 10th, 2017. We aimed to characterize the early impact…
2019 American Transplant Congress
Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease
E. L. Godfrey¹, A. Rana², J. A. Goss²
¹Department of Student Affairs, Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Alcoholic liver disease (ALD) has recently become the most common indication for liver transplantation in the US; it is important to characterize changes in…
2019 American Transplant Congress
Chronic Kidney Disease among Liver Transplant Candidates: A Rising Burden and Its Impact on Post-Liver Transplant Outcomes
G. Cullaro¹, E. C. Verna², B. P. Lee¹, J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY
*Purpose: Chronic kidney disease (CKD) is the end manifestation of persistent renal damage, a pathology distinct from the reversible acute kidney injury (AKI). This distinction…
2019 American Transplant Congress
The Medical Intensive Liver Unit: A Novel Multi-disciplinary Program For The Intensive Care Of Patients With Advanced Liver Disease
C. C. Lindenmeyer¹, G. Flocco¹, A. Sobotka¹, L. Kokoczka², B. Dolan², C. Strauser², C. Romero-Marrero¹, E. Mireles-Cabodevila², H. Khouli², C. Quintini³, A. Kapoor²
¹Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH, ²Department of Critical Care Medicine, Cleveland Clinic, Cleveland, OH, ³Transplantation Center, Cleveland Clinic, Cleveland, OH
*Purpose: Patients with advanced liver disease, particularly those with acute decompensation or acute liver failure (ALF) requiring intensive care unit (ICU) admission, are at elevated…
2019 American Transplant Congress
TIPS Effectively Treats Refractory Hepatic Hydrothorax: A Multi-Center U.S. Retrospective Study of 1,260 Patients
M. German¹, A. Lee¹, A. Hristov¹, A. Said¹, J. Boike², J. Ge³, N. Jest⁴, G. Morelli⁴, K. Kolli³, J. Lai³, A. Desai⁵, S. Junna⁶, B. Pokhrel⁶, T. Couri⁷, S. Paul⁷, C. Frenette⁸, N. Christian-Miller⁸, E. Verna⁹, U. Rahim¹⁰, A. Goel¹⁰, A. Das², S. Pine², D. Gregory², L. VanWagner², E. Spengler¹
¹University of Wisconsin, Madison, WI, ²Northwestern University, Chicago, IL, ³University of California, San Francisco, San Francisco, CA, ⁴University of Florida, Gainesville, FL, ⁵University of Indiana, Indianapolis, IN, ⁶University of Arizona, Tucson, AZ, ⁷University of Chicago, Chicago, IL, ⁸Scripps Clinic, San Diego, CA, ⁹Columbia University, New York, NY, ¹⁰Stanford University, Palo Alto, CA
*Purpose: Hepatic hydrothorax (HHT) occurs in 5-10% of patients with cirrhosis. Current literature on the use of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment…
2019 American Transplant Congress
Hepatocellular Carcinoma in Fontan Liver Disease
V. Lamm¹, J. Wedd², C. Haydek², C. Obineme², A. Noll², H. Veeramachaneni², M. Muftah², R. Ford²
¹Internal Medicine, Emory, Atlanta, GA, ²Emory, Atlanta, GA
*Purpose: To add to the clinical characteristics and outcomes of hepatocellular carcinoma (HCC) in post Fontan operation patients and present, to the best of our…

« Previous Page
1
…
7
8
9
10
11
…
14
Next Page »